Azacitidine Plus Lenalidomide Combination in Elderly Patients With Previously Treated Acute Myeloid Leukemia (AML) & High-Risk Myelodysplastic Syndromes (MDS) (VIREL2 Trial)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01442714

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:42.936699+00:00

Published At

2018-01-03T00:00:00+00:00

Record Updated At

2018-01-03

Results Posted At

2018-01-03

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Leukemia", "Acute Myeloid Leukemia (AML)", "Myelodysplastic Syndromes (MDS)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-01-03"

protocolSection.identificationModule.nctId

"NCT01442714"

protocolSection.identificationModule.officialTitle

"Azacitidine Plus Lenalidomide Combination in Elderly Patients With Previously Treated Acute Myeloid Leukemia (AML) \u0026 High-Risk Myelodysplastic Syndromes (MDS) (VIREL2 Trial)"

protocolSection.statusModule.overallStatus

"TERMINATED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2018-01-03"

Study condition terms

• Leukemia (protocolSection.conditionsModule.conditions)
• Acute Myeloid Leukemia (AML) (protocolSection.conditionsModule.conditions)
• Myelodysplastic Syndromes (MDS) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.